Allergy and immunology lost a pioneer last summer with the death of Marcus Maurer, MD, executive director of the Institute of Allergology at Charité University Medicine, Berlin. Maurer was an author ...

Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

A search for thyroid auto-antibodies is appropriate for all chronic urticarias not responding to first-line therapies with antihistamines, especially when autoimmune urticaria is suspected.

Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

The following is a summary of “Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

Incyte will provide an update on commercial growth, clinical progress and significant 2025 catalysts during a presentation today at 10:30 a.m. PT at the 43rd Annual J.P. Morgan Healthcare Conference ...

Novartis’ immunoglobulin E inhibitor Xolair has been a mainstay of treatment for chronic spontaneous urticaria (CSU) for many years, but the company says it has gone one better with new ...

Clinical guidelines: are systematically developed statements -- including recommendations, algorithms and other information -- intended to provide extensive, critical and well balanced information ...

Integrating physical exercise programs into a multidisciplinary care plan is highly recommended for the management of juvenile idiopathic arthritis-related chronic pain. Physical exercise ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...